Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.52 is 54% below its 5-year average of -1.63, near the low end of its 5-year range (-2.77–-0.83).
8.47% below its 12-month average of -2.32.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.66.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 24 comparable quarters.
EARNINGS PER SHARE (EPS)
-2.52
EARNINGS PER SHARE (EPS) AVG TTM
-2.32
EARNINGS PER SHARE (EPS) AVG 3Y
-1.91
EARNINGS PER SHARE (EPS) AVG 5Y
-1.63
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.47%
CURRENT VS 3Y AVG
-31.74%
CURRENT VS 5Y AVG
-54.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Nyxoah S.A.
Market Cap
$142.10M
Earnings Per Share (EPS)
-2.52
TTM Avg
-2.32
3Y Avg
-1.91
5Y Avg
-1.63
Market Cap
$140.16M
Earnings Per Share (EPS)
-17.42
TTM Avg
-26.05
3Y Avg
-23.35
5Y Avg
-21.03
Market Cap
$144.06M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
Market Cap
$139.78M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.59
3Y Avg
-2.87
5Y Avg
-3.93
Market Cap
$145.29M
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.75
3Y Avg
-3.23
5Y Avg
-3.64
Market Cap
$139.22M
Earnings Per Share (EPS)
-1.04
TTM Avg
-1.66
3Y Avg
-1.77
5Y Avg
-1.60
Market Cap
$145.07M
Earnings Per Share (EPS)
-0.61
TTM Avg
-0.35
3Y Avg
-0.32
5Y Avg
-0.30
Market Cap
$145.55M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.53
3Y Avg
-0.57
5Y Avg
-0.55
Market Cap
$146.18M
Earnings Per Share (EPS)
-12.04
TTM Avg
-8.05
3Y Avg
-55.02
5Y Avg
-123.25
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nyxoah S.A. (NYXH) | $142.10M | -2.52 | -2.32 | -1.91 | -1.63 |
| Sutro Biopharma, Inc. (STRO)vs › | $140.16M | -17.42 | -26.05 | -23.35 | -21.03 |
| Fortress Biotech, Inc. (FBIOP)vs › | $144.06M | 2.68 | -1.38 | -6.44 | -7.90 |
| Alpha Cognition Inc (ACOG)vs › | $139.78M | -1.11 | -1.59 | -2.87 | -3.93 |
| Protara Therapeutics, Inc. (TARA)vs › | $145.29M | -1.36 | -1.75 | -3.23 | -3.64 |
| Immuneering Corporation (IMRX)vs › | $139.22M | -1.04 | -1.66 | -1.77 | -1.60 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $145.07M | -0.61 | -0.35 | -0.32 | -0.30 |
| Anavex Life Sciences Corp. (AVXL)vs › | $145.55M | -0.26 | -0.53 | -0.57 | -0.55 |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.18M | -12.04 | -8.05 | -55.02 | -123.25 |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.03M | -0.04 | -0.09 | -0.17 | -0.13 |
Trailing EPS (TTM)
$-2.52
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.77 |
| 2024-12-31 | -1.87 |
| 2023-12-31 | -1.71 |
| 2022-12-31 | -1.29 |
| 2021-12-31 | -1.32 |
| 2020-12-31 | -0.83 |
| 2019-12-31 | -0.44 |
| 2018-12-31 | -0.49 |
| 2017-12-31 | -0.60 |
